The independent source for health policy research, polling, and news.
39,741 - 39,760 of 112,493 Results
The Republican presidential hopeful's proposal is light on details, but would transfer responsibility for Medicaid to the states, even after he successfully pushed his state to accept the health law's expansion of the program.
In other marketplace news, a judge orders records to be turned over related to a lawsuit over artificial hips made by a unit of Johnson & Johnson. And Bristol-Myers Squibb and Five Prime Therapeutics team to develop medicines for cancer and immune-system disorders.
In most of its tests, the company has stopped collecting blood drawn from the finger in tiny vials, or “nanotainers,” that the Food and Drug Administration considers to be unapproved devices. Theranos says its services are "accurate and reliable."
Shares of Valeant Pharmaceuticals International slumped on news the company received subpoenas from U.S. attorney offices in New York and Massachusetts. The move is another sign that scrutiny of the biotech sector's prices is likely to grow, according to one analyst.
The largest U.S. insurer was initially hesitant about joining the state-based health insurance exchanges. California will be among the new states where UnitedHealth offers plans. News outlets also cover the insurance company's third-quarter earnings reports.
The announcement about premiums and the lack of a Social Security cost-of-living increase made official what many seniors and politicians had been warning: 30 percent of beneficiaries will see their health insurance premiums soar in 2016. The White House and Congress are contemplating fixes, but the effort is mired in the GOP leadership problems on the Hill and budget talks.
Cigna's Florida exit will impact 2016 plans that would have been available through the federal exchange starting Nov. 1. Also in the news, Pennsylvania regulators say the cost of premiums for individual health plans will rise in the year ahead; while Connecticut reports that the state's uninsured rate drops below figures from the U.S. Census.
Because the federal government covers the cost of expansion for the first several years, states that opted for the program are not yet feeling any pinch, according to the research from the Kaiser Family Foundation.
Some news outlets called the forecast of a small increase in enrollment through the health law's insurance exchanges "pessimistic." Officials acknowledged that cost was a concern for some consumers searching for coverage.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
News outlets report on health issues in Missouri, Virginia, Iowa, Pennsylvania, Georgia, Hawaii and California.
Among the ideas being considered are random inspections of any facility, including hospitals, that performs abortions. News outlets also report on other develoments regarding abortion policies or Planned Parenthood in Utah, Texas and Wisconsin.
In Baltimore, Johns Hopkins University and the Hopkins hospital and health system have begun an initiative to alleviate some poverty and improve health. Meanwhile, in Florida, the University of Central Florida is joining forces with HCA to train doctors in the hope that they will stay in the state. Also in Florida, the future of a key hospital funding program is uncertain.
Millions of Americans do not seek dental care, often because they can't afford it. A new mid-level professional that could handle some of the regular care with less expense, might help. In other consumer health news, some employers are offering cash bonuses to workers who find cheaper medical care, telemedicine is opening some doors and retirement health care can be expensive.
The health insurer beat expectations due in part to growth in its pharmacy benefits management business, spurred by a recent purchase of Catamaran.
In other news, Bloomberg examines an effort by top cancer hospitals to provide patients with information about the cost of the drugs used in their treatments. Meanwhile, The Wall Street Journal takes a look at Theranos, and The Washington Post reports that a watchdog group has thrown up a red flag regarding the Food and Drug Administration's review of a blood-thinning drug.
Earlier reviews found similar problems in the federal exchange, healthcare.gov, and exchanges in California, Connecticut and New York. Also in news about the health law, California moves to eliminate a coverage gap, Illinois officials are preparing for some small business changes and Ohio and Utah weigh Medicaid expansion issues.
Meanwhile, Republicans' efforts to recruit Rep. Paul Ryan, R-Wis., to run for speaker of the House continues to draw headlines, speculation and analysis. And the Planned Parenthood controversy continues.
© 2026 KFF